Nippon Chemiphar Co Ltd

Nippon Chemiphar maintains a market price of 1,656 JPY per share, with a market capitalization of 6,004,626,192 JPY. The company's price-to-book ratio is 0.31, and its price-to-tangible-book ratio is also 0.31, indicating a significant discount to its book value. The enterprise value to EBITDA ratio is 64.56, and the enterprise value to revenue ratio is 0.52, both of which are elevated compared to typical industry benchmarks. Profitability metrics show a return on equity of 1.53% and a return on assets of 0.59%, both of which are below the industry median for pharmaceutical companies. The company's operating income of 264 million JPY and net income of 294 million JPY for the latest period reflect modest profitability. The debt-to-equity ratio of 0.94 suggests a moderate level of leverage, but the current ratio of 2.45 indicates sufficient short-term liquidity to cover obligations. The company's revenue is primarily concentrated in Japan and Vietnam, with no disclosed breakdown of segment contributions. The pharmaceutical segment is the core business, but the company also engages in entrusted safety testing, healthcare, and real estate leasing. There is no detailed information on the relative contribution of each segment to total revenue. Looking ahead, the company's revenue is expected to remain stable, with no significant growth or decline projected in the next fiscal year. The operating cash flow is negative at -265 million JPY, and free cash flow is also negative at -369 million JPY, indicating that the company is not generating sufficient cash from operations to fund its activities. Capital expenditures amounted to -1,858 million JPY, suggesting a significant investment in long-term assets. The company faces a medium liquidity risk due to its negative net cash position after subtracting total debt. The risk of dilution is assessed as low, with no immediate pressure for share issuance. The company's risk assessment highlights the need for improved cash flow generation to support its capital structure. Recent events include the publication of the 2023 annual report, which provides a detailed overview of the company's financial performance and strategic direction. There are no recent filings or transcripts indicating significant changes in the company's operations or financial strategy.